Page 1 of Clinical Trials for Chiron Corporation [SPONSOR-COLLABORATORS], 22 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
Kinetic of Immune Memory Response After Re-Vaccination With Meningococcal Vaccine
Last Updated: December 2, 2005
Condition(s): Meningococcal Disease; Meningococcal Meningitis
2
Terminated
Comparing Interleukin-2 (IL-2) Combined With Rituximab (Rituxan) to Rituximab Alone in Subjects With Non-Hodgkin’s Lymphoma (NHL)
Last Updated: February 2, 2006
Condition(s): Non-Hodgkin Lymphoma
3
Completed
Proleukin in Combination With Rituxan in Patients With Intermediate and High-Grade Non-Hodgkin's Lymphoma.
Last Updated: February 2, 2006
Condition(s): Lymphoma, Non-Hodgkin
4
Completed
Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer
Last Updated: July 10, 2006
Condition(s): Esophageal Neoplasms; Stomach Neoplasms; Adenocarcinoma
5
Completed
Proleukin in Combination With Rituxan in Patients With Low-Grade Non-Hodgkin's Lymphoma Who Have Previously Failed Rituxan Treatments
Last Updated: February 2, 2006
Condition(s): Lymphoma, Non-Hodgkin
6
Terminated
Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer
Last Updated: July 10, 2006
Condition(s): Colorectal Neoplasms
7
Completed
A Phase I, Observer-Blind, Placebo-Controlled Study of the Chiron Vaccine HIV p24/MF59 Administered to Healthy HIV-Seronegative Adults
Last Updated: June 23, 2005
Condition(s): HIV Infections; HIV Seronegativity
8
Completed
A Phase I Study of Subcutaneously Administered Proleukin (Aldesleukin) in HIV-Infected Patients
Last Updated: June 23, 2005
Condition(s): HIV Infections
9
Completed
A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) Retinitis
Last Updated: June 23, 2005
Condition(s): Cytomegalovirus Retinitis; HIV Infections
10
Active, not recruiting
Safety and Effectiveness of L2-7001 (Interleukin-2) in HIV-Positive Patients Receiving Anti-HIV Therapy
Last Updated: June 23, 2005
Condition(s): HIV Infections
11
Completed
Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic Individuals
Last Updated: June 23, 2005
Condition(s): HIV Infections
12
Terminated
Safety of CHIR-258 (TKI258) in Advanced Solid Tumors
Last Updated: January 4, 2011
Condition(s): Neoplasms; Cancer; Tumors
13
Completed
Phase I Study of Continuous Infusion Schedule of FMdC in Hematologic Malignancies
Last Updated: October 22, 2010
Condition(s): Hematologic Malignancies
14
Active, not recruiting
Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV
Last Updated: September 25, 2008
Condition(s): HIV Infections
15
Terminated
Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma
Last Updated: April 17, 2008
Condition(s): Non-Hodgkin's Lymphoma
16
Recruiting
Treating Patients With Childhood Acute Myeloid Leukemia With Interleukin-2
Last Updated: February 11, 2009
Condition(s): Leukemia
17
Completed
Phase II Trial of (IL-2) With Priming and (GM-CSF) in Patients With Advanced Melanoma
Last Updated: May 2, 2012
Condition(s): Malignant Melanoma
18
Active, not recruiting
IL-2 Therapy in Lymphodepleted Patients With Metastatic Melanoma
Last Updated: August 2, 2007
Condition(s): Metastatic Melanoma
19
Recruiting
Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization
Last Updated: March 23, 2012
Condition(s): Melanoma
20
Completed
An International Study to Evaluate Recombinant Interleukin-2 (rIL-2) in HIV Positive Patients Taking Anti-retroviral Therapy
Last Updated: February 3, 2012
Condition(s): HIV Infections

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Chiron+Corporation

Page 1 of Clinical Trials for Chiron Corporation [SPONSOR-COLLABORATORS], 22 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About